Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Axalid 25mg capsules
0408010AEBFAAAA
|
Axalid | Pregabalin | Central Nervous System | 166 |
|
Axalid 50mg capsules
0408010AEBFABAB
|
Axalid | Pregabalin | Central Nervous System | 164 |
|
Axalid 150mg capsules
0408010AEBFAEAE
|
Axalid | Pregabalin | Central Nervous System | 158 |
|
Axalid 75mg capsules
0408010AEBFACAC
|
Axalid | Pregabalin | Central Nervous System | 157 |
|
Axalid 100mg capsules
0408010AEBFADAD
|
Axalid | Pregabalin | Central Nervous System | 110 |
|
Axalid 300mg capsules
0408010AEBFAHAG
|
Axalid | Pregabalin | Central Nervous System | 98 |
|
Axalid 200mg capsules
0408010AEBFAFAF
|
Axalid | Pregabalin | Central Nervous System | 64 |
|
Axalid 225mg capsules
0408010AEBFAGAI
|
Axalid | Pregabalin | Central Nervous System | 24 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.